Technical Guide: Angiotensin I/II (1-5) for RAS Research Wor
2026-05-07
Technical Guide to Angiotensin I/II (1-5) in RAS Research
What This Product Solves
Angiotensin I/II (1-5) is a defined peptide fragment (Asp-Arg-Val-Tyr-Ile) derived from the N-terminus of both angiotensin I and II. It enables researchers to model specific aspects of the renin-angiotensin system (RAS), focusing on blood pressure regulation and aldosterone release. The peptide's role as a vasoconstrictor and stimulator of aldosterone release underpins its use in studies targeting cardiovascular or renal physiology. Unlike full-length angiotensin peptides, this fragment offers a controlled approach for dissecting the mechanistic sequence of RAS signaling and is particularly suited for use in hypertension research, aldosterone release stimulation assays, and related blood pressure regulation peptide workflows. For a detailed overview of practical applications and workflow recommendations, consult the Technical Use Guide: Angiotensin I/II (1-5) in RAS Research, which emphasizes the importance of restricting this reagent to cardiovascular and renal studies.Protocol Parameters
- Peptide Dissolution | DMSO ≥66.5 mg/mL, ethanol ≥69.5 mg/mL | Preparation of stock solutions for in vitro assays | Ensures full solubilization due to water insolubility, preventing precipitation or loss of activity in functional assays | product_spec (product_spec)
- Storage Condition | -20°C | Long-term storage for reference standards or working stocks | Maintains peptide integrity by reducing hydrolysis and oxidation over time | product_spec
- Application Scope | Cardiovascular/renal physiology models | Experimental workflows in hypertension, blood pressure regulation, or aldosterone signaling | Matches the defined mechanistic action of the peptide fragment; avoids off-target effects seen in unrelated systems | workflow_recommendation (internal_article)
Workflow Setup and QC Checklist
- Preparation: Dissolve Angiotensin I/II (1-5) in DMSO or ethanol to prepare a concentrated stock solution. Due to its insolubility in water, avoid direct aqueous dissolution to prevent precipitation and inconsistent dosing.
- Aliquoting: Prepare aliquots of the stock solution to minimize freeze-thaw cycles. Each aliquot should be for single-use or limited repeat use to preserve activity.
- Storage: Store all peptide stocks and working solutions at -20°C. Avoid repeated warming to room temperature unless immediately prior to use.
- Solvent Compatibility: Confirm that the final solvent (DMSO or ethanol) is compatible with cell lines or tissue preparations used in your experimental system. Perform a vehicle control where necessary.
- Functional Assay Calibration: Validate the activity of each new batch with a standard assay relevant to RAS research, such as a vasoconstriction or aldosterone release assay.
- Documentation: Record batch numbers, dissolution parameters, and storage timeline for reproducibility.
Common Failure Modes and Fixes
- Peptide Precipitation: Failure to dissolve the peptide in DMSO or ethanol, or attempting direct water dissolution, often results in visible precipitate and loss of effective concentration. Solution: Always use recommended organic solvents for stock preparation and confirm solubility visually before use (source: product_spec).
- Loss of Activity After Storage: Extended exposure to room temperature or repeated freeze-thaw cycles can degrade the peptide, reducing efficacy in functional assays. Solution: Store at -20°C in aliquots and use each aliquot promptly.
- Non-specific Biological Effects: Application outside cardiovascular or renal models may result in uninterpretable data due to the fragment's narrow mechanistic scope. Solution: Restrict use to validated RAS workflows and avoid unrelated peptide signaling systems (source: internal_article).
- Solvent Toxicity: High concentrations of DMSO or ethanol can affect cell viability or tissue function. Solution: Titrate final solvent concentration in assay buffers and always include vehicle controls.